A randomized non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castrat...

Por Hussain, Maha, Rathkopf, Dana, Liu, Glenn, Armstrong, Andrew, Kelly, Wm. Kevin, Ferrari, Anna, Hainsworth, John, Joshi, Adarsh, Hozak, Rebecca R., Yang, Ling, Schwartz, Jonathan D., Higano, Celestia S.
Publicado no Eur J Cancer (2015)

An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer

Por Garcia-Carbonero, Rocio, Rivera, Fernando, Maurel, Joan, Ayoub, Jean-Pierre M., Moore, Malcolm J., Cervantes, Andres, Asmis, Timothy R., Schwartz, Jonathan D., Nasroulah, Federico, Ballal, Shaila, Tabernero, Josep
Publicado em 2014

Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

Por Siegel, Abby B., Cohen, Emil I., Ocean, Allyson, Lehrer, Deborah, Goldenberg, Alec, Knox, Jennifer J., Chen, Helen, Clark-Garvey, Sean, Weinberg, Alan, Mandeli, John, Christos, Paul, Mazumdar, Madhu, Popa, Elizabeta, Brown, Robert S., Rafii, Shahin, Schwartz, Jonathan D.
Publicado em 2008

A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer

Por Zhu, Andrew X., Finn, Richard S., Mulcahy, Mary, Gurtler, Jayne, Sun, Weijing, Schwartz, Jonathan D., Dalal, Rita P., Joshi, Adarsh, Hozak, Rebecca R., Xu, Yihuan, Ancukiewicz, Marek, Jain, Rakesh K., Nugent, Francis W., Duda, Dan G., Stuart, Keith
Publicado no Clin Cancer Res (2013)

A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma(,)

Por Penson, Richard T., Moore, Kathleen M., Fleming, Gini F., Braly, Patricia, Schimp, Veronica, Nguyen, Hoa, Matulonis, Ursula A., Banerjee, Susana, Haluska, Paul, Gore, Martin, Bodurka, Diane C., Hozak, Rebecca R., Joshi, Adarsh, Xu, Yihuan, Schwartz, Jonathan D., McGuire, William P.
Publicado no Gynecol Oncol (2014)